| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.097 | 0.06 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.29 | 0.07 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |